---
figid: PMC7811327__AMS-17-1-91676-g001
figlink: pmc/articles/PMC7811327/figure/f0001/
number: F1
caption: Diagram of phosphatidyl-inositol 3-kinase/serine-threonine kinase pathway.
  Receptor tyrosine kinase activates phosphatidyl-inositol 3-kinase catalytic subunit
  p110 and regulatory subunit p85 that converts phosphatidylinositol 4,5-bisphosphate
  to phosphatidylinositol 3,4,5-trisphosphate and causes serine-threonine kinase membrane
  recruitment and activation, and hence regulating transcription in the cell nucleusRTK
  – receptor tyrosine kinase, PTEN – phosphatase and tensin homologue encoded on chromosome
  10, PIP2 – phosphatidylinositol 4,5-bisphosphate, PIP3 – phosphatidylinositol 3,4,5-trisphosphate,
  PDK1 – 3-phosphoinositide-dependent kinase-1, PP2A – protein phosphatase 2, PH –
  pleckstrin homology domain, AKT – serine-threonine kinase, T308 –threonine 308 phosphorylation
  site at the AKT kinase catalytic domain, S473 – serine 473 phosphorylation site
  at the AKT kinase regulatory domain, PO4 – phosphate group, VEGF – vascular endothelial
  growth factor, p85 – regulatory domain of phosphatidyl-inositol 3-kinase, p110 –
  catalytic domain of phosphatidyl-inositol 3-kinase, PTEN – phosphatase and tensin
  homologue protein acts as a phosphatase to dephosphorylate, PIP3 – this dephosphorylation
  results in inhibition of the AKT signalling pathway.
pmcid: PMC7811327
papertitle: 'Prognostic value of the PIK3CA, AKT, and PTEN mutations in oral squamous
  cell carcinoma: literature review.'
reftext: Anna Starzyńska, et al. Arch Med Sci. 2021;17(1):207-217.
pmc_ranked_result_index: '12104'
pathway_score: 0.95638
filename: AMS-17-1-91676-g001.jpg
figtitle: Diagram of phosphatidyl-inositol 3-kinase/serine-threonine kinase pathway
year: '2021'
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7811327__AMS-17-1-91676-g001.html
  '@type': Dataset
  description: Diagram of phosphatidyl-inositol 3-kinase/serine-threonine kinase pathway.
    Receptor tyrosine kinase activates phosphatidyl-inositol 3-kinase catalytic subunit
    p110 and regulatory subunit p85 that converts phosphatidylinositol 4,5-bisphosphate
    to phosphatidylinositol 3,4,5-trisphosphate and causes serine-threonine kinase
    membrane recruitment and activation, and hence regulating transcription in the
    cell nucleusRTK – receptor tyrosine kinase, PTEN – phosphatase and tensin homologue
    encoded on chromosome 10, PIP2 – phosphatidylinositol 4,5-bisphosphate, PIP3 –
    phosphatidylinositol 3,4,5-trisphosphate, PDK1 – 3-phosphoinositide-dependent
    kinase-1, PP2A – protein phosphatase 2, PH – pleckstrin homology domain, AKT –
    serine-threonine kinase, T308 –threonine 308 phosphorylation site at the AKT kinase
    catalytic domain, S473 – serine 473 phosphorylation site at the AKT kinase regulatory
    domain, PO4 – phosphate group, VEGF – vascular endothelial growth factor, p85
    – regulatory domain of phosphatidyl-inositol 3-kinase, p110 – catalytic domain
    of phosphatidyl-inositol 3-kinase, PTEN – phosphatase and tensin homologue protein
    acts as a phosphatase to dephosphorylate, PIP3 – this dephosphorylation results
    in inhibition of the AKT signalling pathway.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - PDK1
  - VEGFD
  - VEGFB
  - PGF
  - VEGFA
  - VEGFC
  - PLP2
  - SART3
  - AKT2
  - AKT3
  - AKT1
  - PTEN
genes:
- word: PDK1
  symbol: PDK1
  source: hgnc_symbol
  hgnc_symbol: PDK1
  entrez: '5163'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFD
  entrez: '2277'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFB
  entrez: '7423'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: PGF
  entrez: '5228'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFA
  entrez: '7422'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFC
  entrez: '7424'
- word: PIP2
  symbol: PLP2
  source: hgnc_symbol
  hgnc_symbol: PLP2
  entrez: '5355'
- word: p110
  symbol: p110
  source: hgnc_alias_symbol
  hgnc_symbol: SART3
  entrez: '9733'
- word: АКТ
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: АКТ
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: АКТ
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: PTEN
  symbol: PTEN
  source: hgnc_symbol
  hgnc_symbol: PTEN
  entrez: '5728'
- word: АКТ
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: АКТ
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: АКТ
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: АКТ
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: АКТ
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: АКТ
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
chemicals: []
diseases: []
figid_alias: PMC7811327__F1
redirect_from: /figures/PMC7811327__F1
figtype: Figure
---
